Literature DB >> 10488130

An enhanced epithelial response of a papillomavirus promoter to transcriptional activators.

K W Vance1, M S Campo, I M Morgan.   

Abstract

Mucosal epitheliotropic papillomaviruses have a similar long control region (LCR) organization: a promoter region, an enhancer region, and a highly conserved distribution of E2 DNA binding sites. The enhancer of these viruses is epithelial-specific, as it fails to activate transcription from heterologous promoters in nonepithelial cell types (Gloss, B., Bernard, H. U., Seedorf, K., and Klock, G. (1987) EMBO J. 6, 3735-3743; Morgan, I. M., Grindlay, G. J., and Campo, M. S. (1999) J. Gen. Virol. 80, 23-27). Studies on E2 transcriptional regulation of the human mucosal epitheliotropic papillomaviruses have been hindered by poor access to the natural target cell type and by the observation that some of the human papillomavirus promoters, including human papillomavirus-16, are repressed in immortalized epithelial cells. Here we present results using the bovine papillomavirus-4 (BPV-4) LCR and a bovine primary cell system as a model to study the mechanism of E2 transcriptional regulation of mucosal epitheliotropic papillomaviruses and the cell type specificity of this regulation. E2 up-regulates transcription from the BPV-4 LCR preferentially in epithelial cells (Morgan, I. M., Grindlay, G. J., and Campo, M. S. (1998) J. Gen. Virol. 79, 501-508). We demonstrate that the epithelial-specific enhancer element of the BPV-4 LCR is not required for the enhanced activity of E2 in epithelial cells and that the BPV-4 promoter is more responsive, not only to E2, but to other transcriptional activators in epithelial cells. This is the first time a level of epithelial specificity has been shown to reside in a papillomavirus promoter region.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488130     DOI: 10.1074/jbc.274.39.27839

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.

Authors:  K W Vance; M S Campo; I M Morgan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Failure to interact with Brd4 alters the ability of HPV16 E2 to regulate host genome expression and cellular movement.

Authors:  Elaine J Gauson; Xu Wang; Edward S Dornan; Pawel Herzyk; Molly Bristol; Iain M Morgan
Journal:  Virus Res       Date:  2015-09-10       Impact factor: 3.303

3.  Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes.

Authors:  Nathalie Arians; Nils Henrik Nicolay; Stephan Brons; Stefan Alexander Koerber; Christine Jaschke; Marco Vercruysse; Sigrid Daffinger; Alexander Rühle; Jürgen Debus; Katja Lindel
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

4.  Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.

Authors:  Christian T Fontan; Dipon Das; Molly L Bristol; Claire D James; Xu Wang; Hannah Lohner; Azeddine Atfi; Iain M Morgan
Journal:  mSphere       Date:  2020-12-09       Impact factor: 4.389

5.  CK2 Phosphorylation of Human Papillomavirus 16 E2 on Serine 23 Promotes Interaction with TopBP1 and Is Critical for E2 Interaction with Mitotic Chromatin and the Viral Life Cycle.

Authors:  Apurva T Prabhakar; Claire D James; Dipon Das; Raymonde Otoa; Matthew Day; John Burgner; Christian T Fontan; Xu Wang; Sarah H Glass; Andreas Wieland; Mary M Donaldson; Molly L Bristol; Renfeng Li; Anthony W Oliver; Laurence H Pearl; Brian O Smith; Iain M Morgan
Journal:  mBio       Date:  2021-09-21       Impact factor: 7.867

6.  Interaction with TopBP1 Is Required for Human Papillomavirus 16 E2 Plasmid Segregation/Retention Function during Mitosis.

Authors:  Apurva T Prabhakar; Claire D James; Dipon Das; Christian T Fontan; Raymonde Otoa; Xu Wang; Molly L Bristol; Iain M Morgan
Journal:  J Virol       Date:  2022-07-26       Impact factor: 6.549

7.  P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein.

Authors:  Craig Brown; Anna M Kowalczyk; Ewan R Taylor; Iain M Morgan; Kevin Gaston
Journal:  Virol J       Date:  2008-01-11       Impact factor: 4.099

8.  The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.

Authors:  Abida Siddiqa; Karen Campos Léon; Claire D James; Muhammad Faraz Bhatti; Sally Roberts; Joanna L Parish
Journal:  J Gen Virol       Date:  2015-04-24       Impact factor: 3.891

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.